BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Diabetes mellitus
,
Heart
,
Biofuel
,
Rapamycin
,
rs2230926
,
BRCA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
telatinib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vit…
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients wit…
Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with beva…
Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours.
Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhib…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors
A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer
Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer
Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ